Streetbeat News

Regulatory

VTYX

Trading halt status for VTYX was updated at 8:25:00 AM ET. The article provides information on the news and resumption times for the stock.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:25 pm

ABT

EZPW

GPRK

IART

ICL

IMMP

IOVA

NAMS

PDD

Several major stocks, including Abbott Laboratories, Integra LifeSciences, and NewAmsterdam Pharma, experienced significant declines in Monday's pre-market session. Abbott fell due to a $495 million damages order, Integra LifeSciences dropped after lowering its FY24 outlook, and NewAmsterdam Pharma declined following Phase 3 trial results.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 12:24 pm

BITF

BITO

CLSK

COIN

IBIT

MARA

RIOT

Crypto-related stocks surged after Donald Trump expressed support for Bitcoin and promised favorable regulations. Coinbase, Marathon Digital, Bitfarms, Riot Platforms, and CleanSpark saw significant gains. Trump also pledged to create a national Bitcoin stockpile and fire SEC Chair Gary Gensler. Analysts view a potential Trump presidency as positive for the crypto market.

Portfolio Pulse from Anusuya Lahiri

July 29, 2024 | 12:23 pm

VTVT

vTv Therapeutics shares are trading lower after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:21 pm

ASST

Asset Entities Inc. (NASDAQ:ASST) has regained compliance with Nasdaq's minimum bid price requirement, as confirmed by a formal notice from Nasdaq's Office of General Counsel.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:14 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has patented a new camera system for vehicles that projects live feeds onto the windshield, potentially enhancing driver safety. This follows the discontinuation of Apple's decade-long Apple Car project, Project Titan. The patent indicates Apple's continued interest in vehicle technology.

Portfolio Pulse from Rounak Jain

July 29, 2024 | 12:09 pm

ALMS

Alumis has initiated the ONWARD Phase 3 clinical program for ESK-001, targeting moderate-to-severe plaque psoriasis. The study aims to achieve co-primary endpoints PASI 75 and sPGA 0/1 at 24 weeks to support a U.S. regulatory submission. Topline data is expected in 2026.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:03 pm

GRFS

The FDA has approved an expanded label for Grifols' XEMBIFY, making it the first 20% subcutaneous immunoglobulin (SCIg) for treatment-naïve patients with primary humoral immunodeficiencies. The approval includes biweekly dosing, following positive Phase 4 data, enhancing flexibility and convenience for patients.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 12:01 pm

VTYX

Trading for VTYX was halted at 7:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:55 am

BLK

BTCUSD

ETHUSD

Kamala Harris is not favored by the crypto community, while Donald Trump is seen as a pro-crypto candidate. Trump attended the Bitcoin Conference and expressed support for Bitcoin and the crypto market. The SEC has softened its stance on crypto, and new Ethereum ETFs have been launched. Bitcoin is trading above key moving averages, indicating bullish sentiment.

Portfolio Pulse from Kenneth Rapoza

July 29, 2024 | 11:48 am